Since 1997, Catalona et al. [25] advocated prostate biopsy for men with a PSA value in the 2.5- to 4.0-ng/ml range, believing that the use of this parameter increases the detection rate of curable forms of PCa. Here, KLK3 is linked to posterior cortical atrophy.